Frank Lis
President and CEO @ Kineticos Ventures
Doylestown, United States
Frank Lis is a Series A investor at Kineticos Ventures in Doylestown focused on Biotechnology and Health Care. Frank Lis is the current President and CEO of Kineticos Ventures. He previously worked at Sharp Clinical Services as a President. Frank Lis attended Villanova University.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries Frank Lis invests in
Stages Frank Lis invests in
Countries Frank Lis invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Biotechnology 3 (100%)
- Health Care 2 (67%)
- Life Science 2 (67%)
- Wellness 1 (33%)
- Clinical Trials 1 (33%)
Country
- United Kingdom 2 (67%)
- United States 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| eXmoor Pharma is a technical and strategic consultancy specializing in cell and gene therapies (ATMPs) and biopharmaceuticals. | $35M / Series A / May 30, 2023 | ||
| Inceptor Bio develops cell therapy solutions to cure difficult-to-treat cancers, with a focus on novel mechanisms to improve immune cell performance in the tumor microenvironment. Inceptor Bio provides a partnership model to university research programs focused on cutting-edge therapeutic approaches for oncology. The combination of their lab andmanufacturing resources with the industry experience of their cell and gene therapy experts will advance therapeutics into the clinic with remarkable efficiency. | $37M / Series A / May 19, 2022 | ||
| EnteroBiotix is a developer of novel medicinal products intended to restore health and prevent bacterial infections. The company's offerings include developing and advancing novel microbiome-modulating drugs composed of bacterial communities derived directly from the human gastrointestinal tract associated with imbalances of bacteria in thehuman gut, enabling physicians to prevent and treat debilitating infections and diseases. | $21.4M / Series A / Sep 07, 2021 |
Co-Investors
About Kineticos Ventures
Kineticos Ventures Invests in biotechs looking to disrupt how drugs are developed, diseases are diagnosed and patients are treated. We focus on the areas of greatest medical need: Oncology, Neurosciences, and Rare Diseases. We believe that disruptive technologies such as Cell and Gene Therapy, Gene Editing, mRNA/RNAi will dramatically changehow medicine is practiced.
Kineticos Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Frank Lis
President and CEO
|
|||
Shailesh Maingi
Founder & Exec Chair
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Frank Lis invest in?
Frank Lis invests primarily in Biotechnology, Health Care and Life Science startups, most often at Series A stage. Most of the 3 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Frank Lis?
Public channels for Frank Lis include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Frank Lis last invest?
The most recent investment recorded for Frank Lis closed in May 2023. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
